BRAF and thyroid nodule: In this study, the frequency of the BRAF V600E mutation in malignant thyroid nodules was 70.22% (158/225), which was consistent with the results reported in the Chinese population (63.6∼87.7%) and higher than that in the Western population (30∼70%) [8, 29, 30].